158 related articles for article (PubMed ID: 27490848)
1. Effects of a Soluble Epoxide Hydrolase Inhibitor on Lipopolysaccharide-Induced Acute Lung Injury in Mice.
Tao W; Li PS; Yang LQ; Ma YB
PLoS One; 2016; 11(8):e0160359. PubMed ID: 27490848
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of acute lung injury in a rat model by Semen Cassiae.
Chen X; Zhang X; Zhang J; Gao Y; Yang Z; Li S; Dai H
BMC Complement Altern Med; 2017 Apr; 17(1):234. PubMed ID: 28454544
[TBL] [Abstract][Full Text] [Related]
3. Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Zhou Y; Liu T; Duan JX; Li P; Sun GY; Liu YP; Zhang J; Dong L; Lee KSS; Hammock BD; Jiang JX; Guan CX
Shock; 2017 May; 47(5):638-645. PubMed ID: 27753791
[TBL] [Abstract][Full Text] [Related]
4. Effect of Soluble Epoxide Hydrolase in Hyperoxic Acute Lung Injury in Mice.
Li PS; Tao W; Yang LQ; Shu YS
Inflammation; 2018 Jun; 41(3):1065-1072. PubMed ID: 29574653
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
6. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
[No Abstract] [Full Text] [Related]
7. The weakening effect of soluble epoxide hydrolase inhibitor AUDA on febrile response to lipopolysaccharide and turpentine in rat.
Piotrowski J; Jędrzejewski T; Pawlikowska M; Pacuła AJ; Ścianowski J; Kozak W
J Physiol Biochem; 2017 Nov; 73(4):551-560. PubMed ID: 28741242
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
10. Total flavonoids of Inula japonica alleviated the inflammatory response and oxidative stress in LPS-induced acute lung injury via inhibiting the sEH activity: Insights from lipid metabolomics.
Zhang J; Zhang M; Zhang WH; Zhu QM; Huo XK; Sun CP; Ma XC; Xiao HT
Phytomedicine; 2022 Dec; 107():154380. PubMed ID: 36150346
[TBL] [Abstract][Full Text] [Related]
11. Soluble Epoxide Hydrolase Plays a Vital Role in Angiotensin II-Induced Lung Injury in Mice.
Tao W; Li PS; Xu G; Luo Y; Shu YS; Tao YZ; Yang LQ
Shock; 2018 Nov; 50(5):589-594. PubMed ID: 29206762
[TBL] [Abstract][Full Text] [Related]
12. Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury.
Liu LP; Li B; Shuai TK; Zhu L; Li YM
BMC Anesthesiol; 2018 Apr; 18(1):48. PubMed ID: 29703148
[TBL] [Abstract][Full Text] [Related]
13. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.
Liu XX; Yu DD; Chen MJ; Sun T; Li G; Huang WJ; Nie H; Wang C; Zhang YX; Gong Q; Ren BX
Int Immunopharmacol; 2015 Apr; 25(2):370-6. PubMed ID: 25724384
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
Wepler M; Beloiartsev A; Buswell MD; Panigrahy D; Malhotra R; Buys ES; Radermacher P; Ichinose F; Bloch DB; Zapol WM
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1213-L1221. PubMed ID: 27815261
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
16. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
[TBL] [Abstract][Full Text] [Related]
18. Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury.
Lee JW; Park JW; Shin NR; Park SY; Kwon OK; Park HA; Lim Y; Ryu HW; Yuk HJ; Kim JH; Oh SR; Ahn KS
Int J Mol Med; 2016 Sep; 38(3):834-44. PubMed ID: 27431288
[TBL] [Abstract][Full Text] [Related]
19. [Effect of diallyl trisulfide on tumor necrosis factor-alpha expression and nuclear factor-KappaB activity in mice with acute lung injury induced by lipopolysaccharide].
Zhu GJ; Liu JF; Yu ZB; Zhang YX; Hu ZJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):205-8. PubMed ID: 17448272
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.
Sanders WG; Morisseau C; Hammock BD; Cheung AK; Terry CM
Am J Physiol Cell Physiol; 2012 Aug; 303(3):C278-90. PubMed ID: 22621785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
